The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers

Dermal Filler Clinical Trial

Official title:
The Use of a Recombinant DNA-based Hyaluronidase (RDNAH/ Hylenex Recombinant) to Dissolve Fixed Amounts of a Variety of Popular Hyaluronic Acid (HA) Dermal Fillers in Human Subjects.

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether or not Recombinant DNA-based hyaluronidase (RDNAH/Hylenex recombinant), is safe and effective for dissolving hyaluronic acid (HA) dermal fillers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dermal Filler

Clinical Trial Details

NCT number	NCT02654522
Study type	Interventional
Source	Steve Yoelin M.D. Medical Associates, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	January 2016
Completion date	February 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546516` - Safety and Efficacy of the HA-based Dermal Fillers HYAcorp Lips and Face
Completed	`NCT04546152` - Safety and Efficacy of the HA-based Dermal Fillers HYAPROF® SOFT and HYAPROF® BALANCE
Active, not recruiting	`NCT05694286` - A Prospective Evaluation of Infraorbital Filler Injection	N/A
Completed	`NCT05822778` - Formaderm (Hyaluronic Acid) for Facial Soft Tissue Augmentation	N/A
Completed	`NCT05294562` - China Post-Market Clinical Follow-up of FACILLE®
Completed	`NCT04569045` - Evaluate the Safety and Effectiveness of Sodium Hyaluronate When Used for the Correction of Nasolabial Folds	N/A
Completed	`NCT04622085` - The Evaluation of the Safety and Effectiveness of ANIMERS Chiara LA and JUVÉDERM VOLUMA® for Aging Mid-Face	N/A
Completed	`NCT04599335` - The Evaluation of the Safety and Effectiveness of a Novel Gel-type Sodium Hyaluronate for the Correction of Aging Mid-face	N/A
Recruiting	`NCT05853224` - An Interventional Study to Evaluate the Safety and Performance of Crosslinked Hyaluronic Acid Hydrogel	N/A